A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

NCT00002084 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Herpes Simplex
HIV Infections

Interventions

DRUG: Valacyclovir hydrochloride
DRUG: Acyclovir

Sponsor

Glaxo Wellcome